This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: King Faisal University. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Abdulla Yousef Al-Taher: Innovator in Antiviral and Antifungal Treatments
Introduction
Abdulla Yousef Al-Taher is a prominent inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the fields of antiviral and antifungal treatments, holding a total of 3 patents. His innovative work focuses on developing peptides and methods that target viral and fungal infections.
Latest Patents
One of Al-Taher's latest patents is for Anti-SARS-CoV-2 fusion peptides. These peptides include sequences that correspond to the SARS-CoV-2 fusion complex heptad repeat domain HR2, featuring at least one artificial mutation. The peptides, such as peptides #121 (SEQ ID NO: 2) and #125 (SEQ ID NO: 5), are designed to competitively bind to SARS-CoV-2, preventing membrane-mediated fusion and endocytosis-mediated viral entry. This innovation has the potential to inhibit or prevent SARS-CoV-2 cellular entry in subjects in need.
Another significant patent involves the treatment of fungal infections using dabigatran etexilate. This method includes administering a therapeutically effective amount of dabigatran etexilate to treat a variety of fungal pathogens. The broad-spectrum antifungal agent can be used for both topical and systemic fungal infections, showcasing its versatility in medical applications.
Career Highlights
Abdulla Yousef Al-Taher is affiliated with King Fahd University of Petroleum and Minerals, where he conducts his research and development work. His academic background and professional experience have positioned him as a key figure in the innovation of medical treatments.
Collaborations
Al-Taher has collaborated with notable colleagues, including Mahmoud Elsayed and Hyung-Joo Kwon. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Abdulla Yousef Al-Taher is a distinguished inventor whose work in antiviral and antifungal treatments has the potential to make a significant impact on public health. His innovative patents reflect his commitment to addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile